CD BioSciences, a US-based biotechnology company focusing on the development of imaging technology, announced the launch of its new 3D Tissue Imaging Services to researchers with comprehensive solutions for 3D imaging of tissues, including 3D Immunolabeling, Tissue Removal, 3D Imaging, and Quantitative Image Analysis. Traditional tissue analysis typically uses frozen or paraffin-embedded sections. Micron-thick tissue sections enable the labeling and characterization of individual cells but do...